Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril orodispersible minitablets in young children with heart failure due to congenital heart disease
2015-002396-18Phase 3Completed
- Sponsor
- Ethicare Clinical Trial Services
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of enalapril in Heart failure due to congenital heart disease (HF-CHD) and Cardiovascular Malformation (CVM), sponsored by Ethicare Clinical Trial Services. Primary endpoint: Primary pharmacokinetic endpoint. Started Sep 2015; status: completed.
02
Drugs
enalapril
03
Conditions
Heart failure due to congenital heart disease (HF-CHD)Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on 2015-002396-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002396-18.